Implantica presents a robust health economic analysis of RefluxStop™ conducted by University of York, UK
Implantica AG (publ), a MedTech company at the forefront of the upcoming eHealth revolution, has received from University of York’s (UK) Health Economics Consortium an in-depth and comprehensive health economic analysis for RefluxStop™ versus alternative surgical and medical treatments.This rigorous analysis clearly shows the superior cost-effectiveness of RefluxStop™ against other anti-reflux medical and surgical treatment interventions (including Standard of Care fundoplication, Magnetic augmentation device and PPI medical treatment). The outcome of this assessment highlights